ENBUCRILATE


Synonyms	Enbucrilate Glustitch Histoacryl Indermil Medibond Medicryl N-butyl cyanoacrylate N-butyl-2-cyanoacrylate Periacryl Vetbond
Status
Molecule Category	UNKNOWN
UNII	F8CEP82QNP
EPA CompTox	DTXSID5064417


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Structure


InChI Key	JJJFUHOGVZWXNQ-UHFFFAOYSA-N
Smiles	C=C(C#N)C(=O)OCCCC
InChI	InChI=1S/C8H11NO2/c1-3-4-5-11-8(10)7(2)6-9/h2-5H2,1H3

Physicochemical Descriptors

Property Name	Value
Molecular Formula	C8H11NO2
Molecular Weight	153.18
AlogP	1.41
Hydrogen Bond Acceptor	3.0
Hydrogen Bond Donor	0.0
Number of Rotational Bond	4.0
Polar Surface Area	50.09
Molecular species	None
Aromatic Rings	0.0
Heavy Atoms	11.0

Related Entries

Cross References

Resources	Reference
ChEBI	134778
ChEMBL	CHEMBL2104251
DrugBank	DB12358
DrugCentral	3056
FDA SRS	F8CEP82QNP
KEGG	C13415
PubChem	23087
SureChEMBL	SCHEMBL24796
ZINC	ZINC000002033854

CONTENTS


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).